Patent · US Active

Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof

US9969803B2 · kind B2 · utility

0Cited by
2References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 4, 2016
Grant dateMay 15, 2018
Priority date—
Expiry dateApr 4, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Monoclonal antibodies against LRP6 and that block the Wnt signaling pathway are disclosed. Methods of production and use thereof are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.